A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
Clinical trial NCT01616303 · COMPLETED
Trial details
- NCT number
- NCT01616303
- Sponsor
- Quest PharmaTech Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-15
- Primary completion
- 2015-06-15
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.